“Article: Clinically meaningful survival benefit with atezolizumab + nab-paclitaxel in previously untreated patients with PD-L1+ metastatic triple negative breast cancer” has been added to your cart. View cart
Article: P.16 Expression of TMEM45A, a candidate gene of chemoresistance, in a panel of neoplastic tissues